Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemicResearch article Published on 2021-11-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] SARS, 치료법, [키워드] affected approved changed children country COVID-19 COVID-19 pandemic current demographic data disease Disease modifying therapy effective Escalation fingolimod FIVE future therapeutic group International MS Multiple multiple sclerosis off-label outcome paediatric pandemic Patient performed Result sclerosis Therapies therapy Treatment Trial understanding [DOI] 10.1016/j.msard.2021.103277 [Article Type] Research article
COVID-19 and Ivermectin: Potential threats associated with human useResearch article Published on 2021-11-012022-10-05 Journal: Journal of Molecular Structure [Category] 신약개발, [키워드] Analysis anti-SARS-CoV-2 candidate clinical trial COVID-19 COVID-19 virus CVID-19 virus dosage drug Drug analysis drug candidate Efficacy human coronavirus Ivermectin manuscript off-label Pathogens Potential Prophylactic required Safety SARS-CoV-2 shown threat Threats Toxicity Treatment virus [DOI] 10.1016/j.molstruc.2021.130808 [Article Type] Research article
COVID-19: Overview of rheumatology fellowsCOVID-19: 류마티스 펠로우 개요Article Published on 2021-11-012022-09-11 Journal: Reumatología clinica [Category] 치료제, [키워드] activity arteritis Arthritis Biological Biological agents Biológicos Case series coronavirus country COVID-19 demonstrated drug drugs English front line giant cell giant cell arteritis health emergency health system immune disorder Infection lack management observational studies observational study off-label Pandemia pandemic para patients randomised clinical trial Randomised clinical trials RCTs resident Residente Resilience Reumatólogos rheumatologist Rheumatologists. rheumatology SARS-COV-2 infection Spanish Spread the disease Therapeutic approach treat Treatment World War World War II Wuhan Wuhan, China [DOI] 10.1016/j.reumae.2020.05.001 PMC 바로가기 [Article Type] Article
Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19COVID-19에 대한 활동을 입증 한 승인 된 약물의 선택과 관련된 독성 위험의 계산 결정Research Published on 2021-10-212022-08-31 Journal: BMC Pharmacology & Toxicology [Category] 신약개발, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 approach approved approved drug Cardiotoxicity caused clinical assessment clinical trial clinical trials Compound computational tool coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 treatment demonstrated disease drug Drug discovery excretion expected facilitate FIVE global pandemic healthcare in silico independent knowledge majority manuscript metabolism molecules non-toxic off-label Patient pharmacological Practitioner predict profile receive repurposing Repurposing drugs, hERG) researcher respiratory Result risk safety profile SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe pneumonia significantly Spread Stratification supplementary material therapeutic therapeutic agent therapy Toxicity treating COVID-19 Treatment treatment for COVID-19 Usage Vaccine Vaccines [DOI] 10.1186/s40360-021-00519-5 PMC 바로가기 [Article Type] Research
Multiple sclerosis and COVID-19: The Swedish experience다발성 경화증과 COVID-19: 스웨덴의 경험Review Published on 2021-09-012022-09-12 Journal: Acta neurologica Scandinavica [Category] 진단, [키워드] addition anti-CD20 therapy Care Complication concern country COVID-19 COVID-19 pandemic COVID-19 vaccination Disease-modifying therapies groups Health healthcare healthcare management implementation Infection lack management Multiple multiple sclerosis National national guideline off-label outcome measure Patient raised Rapid recent recommendation response risk risk factor risk groups severe COVID-19 Swedish telemedicine consultation therapy [DOI] 10.1111/ane.13453 PMC 바로가기 [Article Type] Review
Evaluation of four in silico biomarkers for drug-induced proarrhythmic risk: COVID-19 off-label therapies case studyConference abstract Published on 2021-09-012022-10-05 Journal: Journal of Pharmacological and Toxicological Methods [Category] 바이오마커, [키워드] Biomarker COVID-19 in silico off-label therapy [DOI] 10.1016/j.vascn.2021.107052 [Article Type] Conference abstract
Health emergencies and interoceptive sensibility modulate the perception of non-evidence-based drug use: Findings from the COVID-19 outbreakResearch Article Published on 2021-08-262022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] absence Administered assessment Awareness Care Characteristics COVID-19 COVID-19 outbreak COVID-19 pandemic dramatic increase Emergency experimental drug finding First wave Health Healthcare system Hypothesis Italian Italy modulate off-label pandemic participant Patient physician predicted Prevent questionnaire scientific evidence tested therapeutic Therapeutic approach therapeutic approaches therapeutic decision virus Volume [DOI] 10.1371/journal.pone.0256806 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future ChallengesIBD의 SARS-CoV-2 예방 접종: 과거 교훈, 현재 증거 및 미래 과제Review Published on 2021-08-022022-09-11 Journal: Journal of Crohn's & colitis [Category] SARS, 변종, [키워드] cellular challenge Community complications of COVID-19 COVID-19 current Effectiveness Evidence Future high risk humoral IBD identify immune response immune responses immunogenicity immunosuppressive immunosuppressive therapy in some individual Infection Inflammatory bowel disease inflammatory bowel diseases knowledge lAbel off-label pandemic Patient patients SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines therapy translated trials vaccination Vaccination strategies Vaccination strategy Vaccine Vaccines variants were excluded [DOI] 10.1093/ecco-jcc/jjab046 PMC 바로가기 [Article Type] Review
A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic원격 의료 기반 무작위 통제 시험: COVID-19 전염병 동안 오프 라벨 약물의 외래 환자 시험을 위한 모델Article Published on 2021-08-012022-09-11 Journal: Clinical Trials (London, England) [Category] SARS, 임상, [키워드] COVID-19 pandemic medication off-label Randomized Registered Trial [DOI] 10.1177/17407745211011577 PMC 바로가기 [Article Type] Article
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensionsCOVID-19 환자 관리의 회복기 혈장 요법-새로운 차원Observational Study Published on 2021-08-012022-09-12 Journal: Transfusion clinique et biologique : journal de la [Category] MERS, SARS, 임상, 진단, [키워드] age applied approval Blood Group caused Committee complete recovery conducted control group convalescent plasma COVID 19 COVID 19 infection COVID 19 patients COVID patient COVID-19 Critical decrease Department dimension discharge Early transfusion effective expert family female Female patients highest Infection management material Mortality Neutralizing antibody titer Neutralizing titer Novel coronavirus off-label outcome Oxygen therapy Patient patients plasma therapy positive Prospective Study standard treatment therapeutic transfused Treatment two group Welfare [DOI] 10.1016/j.tracli.2021.04.009 PMC 바로가기 [Article Type] Observational Study